中国速度碾压马斯克！脑机接口企业临床植入总例数有望迈向全球第一

Core Viewpoint - The article highlights a significant milestone in China's brain-computer interface (BCI) sector, with the approval of the first invasive BCI medical device for clinical application, marking a global first in this field [3]. Group 1: Industry Developments - The National Medical Products Administration has approved the innovative product registration application for the implanted BCI hand movement compensation system by Borui Kang Medical Technology (Shanghai) Co., Ltd, indicating the entry of invasive BCI medical devices into clinical use [3]. - The Chinese government has proposed the establishment of a mechanism for future industry investment growth and risk sharing, focusing on future industries such as BCI, which is expected to experience explosive growth [3]. - The BCI sector in China is witnessing accelerated financing, with companies like Gestalt Technology and Ladder Medical securing significant funding rounds recently, including 150 million RMB and 500 million RMB respectively [3][4]. Group 2: Clinical Trials and Market Potential - Ladder Medical plans to conduct large-scale multi-center clinical trials by mid-2026, aiming to exceed the total number of clinical implants by Neuralink, which currently stands at approximately 21 cases [5]. - Predictions suggest that within the next three to five years, BCI technology could see practical applications in China, with the potential for significant advancements in the field [5]. - The domestic BCI market is projected to reach 5.58 billion RMB by 2027, supported by the inclusion of certain BCI treatment technologies in the national medical insurance system in select provinces [6]. Group 3: Advantages and Challenges - China possesses several advantages in the BCI field, including a large population, substantial patient demand, a cost-effective industrial chain, and a rich talent pool in science, technology, engineering, and mathematics [6]. - The journey from experimentation to clinical trials is lengthy, but many Chinese hospitals have established BCI research laboratories to expedite the clinical application process [7].